| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 7,208,767 | 7,691,637 | 7,175,956 | | Cost of Revenue | 4,034,374 | 4,139,147 | 3,813,386 | | | Gross Profit | 3,174,393 | 3,552,490 | 3,362,570 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,387,780 | 1,334,256 | 1,232,449 | | Non Recurring | 1,234,251 | 92,105 | (3,583) | | Others | 778,236 | 700,334 | 629,627 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (225,874) | 1,425,795 | 1,504,077 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 104,460 | 1,237,619 | (3,898) | | Earnings Before Interest And Taxes | (59,702) | 2,866,771 | 1,738,287 | | Interest Expense | 609,286 | 708,343 | 760,361 | | Income Before Tax | (668,988) | 2,158,428 | 977,926 | | Income Tax Expense | 186,298 | 757,883 | 341,930 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (855,286) | 1,400,545 | 635,996 | | | Non-recurring Events | | Discontinued Operations |
-
| 183,874 | 12,268 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (855,286) | 1,584,419 | 648,264 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($855,286) | $1,584,419 | $648,264 |
|
1.48% Nasdaq 
Income Statement
